CD34 and HIV infectious disease: The findings from this study may highlight the potential of anti-HIV treatments such as gene therapy using CD34+ HSPCs followed by transplantation because in this manner, all hematopoietic events in the host can be protected against HIV infection by the gene products even in the absence of effective immune responses (89).